A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development

Journal of Medicinal Chemistry

Volumn 51, Issue 11, 2008, Pages 3116-3123

  Korde, Reshma ^a   Bhardwaj, Ashima ^a   Singh, Rita ^b   Srivastava, Anand ^a   Chauhan, Virander S ^a   Bhatnagar, Raj K ^a   Malhotra, Pawan ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTENNAPEDIA PROTEIN; ANTIMALARIAL AGENT; CYSTEINE PROTEINASE; FALCIPAIN 2; HEMOGLOBIN; HYBRID PROTEIN; PEPTIDE DERIVATIVE;

ANIMAL CELL; ANTIMALARIAL ACTIVITY; ARTICLE; DRUG SCREENING; DRUG SELECTIVITY; DRUG TARGETING; ENZYME INHIBITION; ENZYME SPECIFICITY; ERYTHROCYTE; HYDROLYSIS; IN VITRO STUDY; INTERNALIZATION; MALARIA; MEROZOITE; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PROTEIN DOMAIN; PROTEIN FAMILY;

ANIMALS; ANTIMALARIALS; CYSTEINE ENDOPEPTIDASES; ERYTHROCYTES; HEMOGLOBINS; HYDROLYSIS; PEPTIDES; PLASMODIUM FALCIPARUM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 44949174908     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm070735f     Document Type: Article

References (50)

1. Wu, Y.; Wang, X.; Liu, X.; Wang, Y. Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite. Genome Res. 2003, 4, 601-616.
2. Banerjee,R.; Goldberg, D. E. The Plasmodium food vacuole. In Antimalarial Chemotherapy: Mechanism of Action, Resistance and New Directions in Drug Discovery. Rosenthal, P. J. Ed.; Humana Press: Totowa, NJ, 2000; pp 43-63.
3. Rosenthal, P. J.; Sijwali, P. S.; Singh, A.; Shenai, B. R. Cysteine proteases of malaria parasites: targets for chemotherapy. Curr. Pharm. Des. 2002, 8 (18), 1659-1672.
4. Liu, J.; Istvan, E. S.; Gluzman, I. Y.; Gross, J.; Goldberg, D. E. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (23), 8840-8845.
5. Salmon, A. L.; Oksman, A.; Goldberg, D. E. Malaria parasite exit from the host erythrocyte: A two-step process requiring extraerythrocytic proteolysis. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 271-276.
6. Wickham, M. E.; Culvenor, J. G.; Cowman, A. F. Selective inhibition of a two-step egress of malaria parasites from the host erythrocyte. J. Biol. Chem. 2003, 278 (39), 37658-37663.
7. Greenbaum, D. C.; Baruch, A.; Grainger, M.; Bozdech, Z.; Medzihradszky, K. F.; Engel, J.; DeRisi, J.; Holder, A. A.; Bogyo, M. A role for the protease falcipain-1 in host cell invasion by the human malaria parasite. Science 2002, 298 (5600), 2002-2006.
8. Sijwali, P. S.; Kato, K.; Seydel, K. B.; Gut, J.; Lehman, J.; Klemba, M.; Goldberg, D. E.; Miller, L. H.; Rosenthal, P. J. Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (23), 8721-8726.
9. Sijwali, P. S.; Rosenthal, P. J. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (13), 4384-4389.
10. Kumar, A.; Kumar, K.; Korde, R.; Puri, S. K.; Malhotra, P.; Chauhan, V. S. Falcipain-1, a Plasmodium falciparum cysteine protease with vaccine potential. Infect. Immun. 2007, 75 (4), 2026-2034.
11. Rosenthal, P. J. Cysteine proteases of malaria parasites. Int. J. Parasitol. 2004, 34 (13-14), 1489-1499.
12. Rzychon, M.; Chmiel, D.; Stec-Niemczyk, J. Modes of inhibition of cysteine proteases. Acta. Biochim. Pol. 2004, 51 (4), 861-873.
13. Yamamoto, Y.; Kurata, M.; Watabe, S.; Murakami, R.; Takahashi, S. Y. Novel cysteine proteinase inhibitors homologous to the proregions of cysteine proteinases. Curr. Protein Pept. Sci. 2002, 3 (2), 231-238.
14. Lazure, C. The peptidase zymogen proregions: nature's way of preventing undesired activation and proteolysis. Curr. Pharm. Des. 2002, 8 (7), 511-531.
15. Jean, L.; Hackett, F.; Martin, S. R.; Blackman, M. J. Functional characterization of the propeptide of Plasmodium falciparum subtilisin-like protease-1. J. Biol. Chem. 2003, 278 (31), 28572-28579.
16. Wiederanders, B.; Kaulmann, G.; Schilling, K. Functions of propeptide parts in cysteine proteases. Curr. Protein Pept. Sci. 2003, 5, 309-326.
17. Silva, F. B.; Batista, J. A.; Marra, B. M.; Fragoso, R. R.; Monteiro, A. C.; Figueira, E. L.; Grossi-de-Sa, M. F. Pro domain peptide of HGCP-Iv cysteine proteinase inhibits nematode cysteine proteinases. Genet. Mol. Res. 2004, 3 (3), 342-355.
18. Tang, B.; Nirasawa, S.; Kitaoka, M.; Hayashi, K. The role of N-terminal propeptide of the pro-aminopeptidase processing protease: refolding, processing, and enzyme inhibition. Biochem. Biophys. Res. Commun. 2002, 296, 78-84.
19. Tang, B.; Nirasawa, S.; Kitaoka, M.; Marie-Claire, C.; Hayashi, K. General function of N-terminal propeptide on assisting protein folding and inhibiting catalytic activity based on observations with a chimeric thermolysin-like protease. Biochem. Biophys. Res. Commun. 2003, 301 (4), 1093-1098.
20. Muntener, K.; Willimann, A.; Zwicky, R.; Svoboda, B.; Mach, L.; Baici, A. Folding competence of N-terminally truncated forms of human procathepsin B. J. Biol. Chem. 2005, 280 (12), 11973-11980.
21. Shenai, B. R.; Sijwali, P. S.; Singh, A.; Rosenthal, P. J. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J. Biol. Chem. 2000, 275 (37), 29000-29010.
22. Godat, E.; Chowdhury, S.; Lecaille, F.; Belghazi, M.; Purisima, E. O.; Lalmanach, G. Inhibition of a cathepsin L-like cysteine protease a chimeric propeptide-derived inhibitor. Biochemistry 2005, 44 (31), 10486-10493.
23. Roche, L.; Tort, J.; Dalton, J. P. The propeptide of Faciola hepatica Cathepsin L is a potent and selective inhibitor of mature enzyme. Mol. Biochem. Parasitol. 1999, 98, 271-277.
24. Chagas, J. R.; Ferrer-Di Martino, M.; Gauthier, F.; Lalmanach, G. Inhibition of cathepsin B by its propeptide: use of overlapping peptides to identify a critical segment. FEBS Lett. 1996, 392 (3), 233-236.
25. Lalmanach, G.; Lecaille, F.; Chagas, J. R.; Authie, E.; Scharfstein, J.; Juliano, M. A.; Gauthier, F. Inhibition of trypanosomal cysteine proteinases by their propeptides. J. Biol. Chem. 1998, 273 (39), 25112-25116.
26. Pandey, K. C.; Wang, S. X.; Sijwali, P. S.; Lau, A. L.; McKerrow, J. H.; Rosenthal, P. J. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif. Proc. Natl. Acad. Sci U.S.A. 2005, 102 (26), 9138-9143.
27. Wang, W. M.; Ge, G.; Lim, N. H.; Nagase, H.; Greenspan, D. S. TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2. Biochem. J. 2006, 398 (3), 515-519.
28. Kumar, A.; Dasaradhi, P. V. N.; Chauhan, V. S.; Malhotra, P. Exploring the role of putative active site amino acids and pro-region motif of recombinant falcipain-2, a principal hemoglobinase of Plasmodium falciparum. Biochem. Biophys. Res. Commun. 2004, 317 (1), 35-45.
29. Sijwali, P. S.; Shenai, B. R.; Rosenthal, P. J. Folding of the Plasmodium falciparum cysteine protease falcipain-2 is mediated by a chaperone-like peptide and not the prodomain. J. Biol. Chem. 2002, 277 (17), 14910-14915.
30. Karrer, K. M.; Peiffer, S. L.; DiTomas, M. E. Two Distinct Gene Subfamilies within the Family of Cysteine Protease Genes. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 3063-3067.
31. + stimulus in Plasmodium. Mol. Biochem. Parasitol. 2005, 141, 71-79.
32. Dhawan, S.; Dua, M.; Chishti, A. H.; Hanspal, M. Ankyrin peptide blocks falcipain-2-mediated malaria parasite release from red blood cells. J. Biol. Chem. 2003, 278 (32), 30180-30186.
33. Cote, J.; Richard, S. Tudor domains bind symmetrical dimethylated arginines. J. Biol. Chem. 2005, 280, 28476-28483.
34. Rosenthal, P. J. Plasmodium falciparum: Effects of Proteinase inhibitors on Globin Hydrolysis by cultured malaria parasites. Exp. Parasitol. 1995, 80, 272-281.
35. Dasaradhi, P. V.; Mohammed, A.; Kumar, A.; Hossain, M. J.; Bhatnagar, R. K.; Chauhan, V. S.; Malhotra, P. A role of falcipain-2, principal cysteine proteases of Plasmodium falciparum in merozoite egression. Biochem. Biophys. Res. Commun. 2005, 336 (4), 1062-1068.
36. McKerrow, J. H.; McGrath, M. E.; Engel, J. C. The cysteine protease of Trypanosoma cruzi as a model for antiparasite drug design. Parasitology Today 1995, 11, 279-282.
37. Olson, J. E.; Lee, G. K.; Semenov, A.; Rosenthal, P. J. Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors. Bioorg. Med. Chem. 1999, 7, 633-638.
38. Lee, B. J.; Singh, A.; Chiang, P.; Kemp, S. J.; Goldman, E. A.; Weinhouse, M. I.; Vlasuk, G. P.; Rosenthal, P. J. Antimalarial activities of novel synthetic cysteine protease inhibitors. Antimicrob. Agents Chemother. 2003, 47 (12), 3810-3814.
39. Na, B. K.; Shenai, B. R.; Sijwali, P. S.; Choe, Y.; Pandey, K. C.; Singh, A.; Craik, C. S.; Rosenthal, P. J. Identification and biochemical characterization of vivapains, cysteine proteases of the malaria parasite Plasmodium vivax. Biochem. J. 2004, 378 (2), 529-538.
40. Shenai, B. R.; Lee, B. J.; Alvarez-Hernandez, A.; Chong, P. Y.; Emal, C. D.; Neitz, R. J.; Roush, W. R.; Rosenthal, P. J. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones. Antimicrob. Agents Chemother. 2003, 47 (1), 154-160.
41. Harris, P. K.; Yeoh, S.; Dluzewski, A. R.; O'Donnell, R. A.; Withers-Martinez, C.; Hackett, F.; Bannister, L. H.; Mitchell, G. H.; Blackman, M. J. Molecular identification of a malaria merozoite surface sheddase. PLoS Pathog. 2005, 1 (3), 241-251.
42. Kreusch, S.; Fehn, M.; Maubach, G.; Nissler, K.; Rommerskirch, W.; Schilling, K.; Weber, E.; Wenz, I.; Wiederanders, B. An evolutionary conserved tripartite tryptophan motif stabilizes the prodomain of cathepsin L-like cysteine proteases. Eur. J. Biochem. 2000, 267, 2965-2972.
43. Tahir, A. E. L.; Malhotra, P.; Chauhan, V. S. Uptake of proteins and degradation of human serum albumin by Plasmodium falciparum-infected human erythrocytes. Malaria J. 2003, 2, 11.
44. Harrison, T.; Samuel, B. U.; Akompong, T.; Hamm, H.; Mohandas, N.; Lomasney, J. W.; Haldar, K. Erythrocyte G protein-coupled receptor signaling in malaria infection. Science 2003, 301, 1734-1735.
45. Murphy, S. C.; Harrison, T.; Hamm, H. E.; Lomasney, J. W.; Mohandass, N.; Haldar, K. Erythrocyte G protein as a novel target for malarial chemotherapy. PLoS Med. 2006, 3 (12), e528.
46. Semenov, A.; Olson, J. E.; Rosenthal, P. J. Antimalarial synergy of cysteine and aspartic protease inhibitors. Antimicrob. Agents. Chemother. 1998, 48, 2254-2258.
47. Trager, W.; Jensen, J. B. Human malaria parasites in continuous culture. Science 1976, 193 (4254), 673-675.
48. Wickham, M. E.; Rug, M.; Ralph, S. A.; Klonis, N.; McFadden, G. I.; Tilley, L.; Cowman, A. F. Trafficking and assembly of cytoadherence complex in Plasmodium falciparum-infected human erythrocytes. Embo. J. 2001, 20, 5636-5649.
49. Lambros, C.; Vanderberg, J. P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 1979, 65 (3), 418-420.
50. Malhotra, P.; Dasaradhi, P. V.; Kumar, A.; Mohmmed, A.; Agrawal, N.; Bhatnagar, R. K.; Chauhan, V. S. Double-stranded RNA-mediated gene silencing of cysteine proteases (falcipain-1 and -2) of Plasmodium falciparum. Mol. Microbiol. 2002, 45 (5), 1245-1254.